Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy
NCT05322252Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2022
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mifepristone in intrauterine fetal demise (IUFD), Pregnancy loss, premature rupture of membranes (PROM), sponsored by Washington University School of Medicine. Started Jul 2022; status: completed.
02
Drugs
mifepristone
03
Conditions
intrauterine fetal demise (IUFD)Pregnancy losspremature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT05322252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322252.